Placebo Current Events | Placebo News | 3
|
| Page
3 of
26 |
519 Results |
|
|
|
Sort By:
Page Views | Date |
Doubling of steroids before severe asthma attacks ineffective (p 271)
Recommendations to double inhaled steroids at the start of asthma attacks are challenged by research findings in this week's issue of THE LANCET. Doubling the dose of inhaled corticosteroid when asthma control deteriorates is widely advocated but is of unproven value. Tim Harrison from the department of respiratory medicine, Nottingham City... view more... (2004-01-21)
Prostate cancer immunotherapy significantly prolongs survival in men with advanced prostate cancer
Sipuleucel-T (Provenge), an experimental immunotherapy improved survival in men with metastatic disease, according to new results to be presented April 28 at the American Urological Association (AUA) Annual Scientific Meeting in Chicago. view more (2009-04-29)
Relapse from antidepressant medication may be lack of response to medication in the first place
A new study by Rhode Island Hospital researchers indicates that a relapse during antidepressant continuation treatment may be due to a relapse in patients who were not true drug responders. view more (2007-08-15)
Research Shows Cherry Juice May Prevent Muscle Damage Pain
The familiar "no pain, no gain" phrase usually associated with exercise may be a thing of the past if results from a study on cherry juice published today in the online version of the British Journal of Sports Medicine prove true in future research. view more (2006-06-23)
Medicine proves a promising treatment in the battle against alcohol dependence
Researchers at the University of Virginia have led a multisite clinical trial showing that the drug topiramate is significantly more efficacious than placebo at curbing alcohol dependence. Subjects had to be drinking heavily and were not abstinent when they started the trial. view more (2007-10-10)
Hormone therapy boosts sexual interest but not memory, study finds
Hormone therapy in early post-menopause increases sexual interest, but does not improve memory, according to a study in the Sept. 25 issue of the journal Neurology. view more (2007-09-25)
Zinc can help in the treatment of pneumonia (pp 1683)
The addition of zinc to standard antimicrobial treatment may accelerate recovery from pneumonia, say researchers in this week's issue of THE LANCET. Pneumonia is a leading cause of mortality and morbidity in children less than five years old. Zinc is reported to prevent pneumonia, and to prevent and treat diarrhoea, and it may boost the body's... view more... (2004-05-19)
Prolonged use of ramipril prevents stroke
Patients who are at high risk of stroke should be treated with the drug ramipril, irrespective of their initial blood pressure levels and in addition to other preventive treatments such as blood pressure lowering agents or aspirin, finds a study in this week’s BMJ. view more (2002-03-20)
THE LANCET NEUROLOGY PRESS RELEASE JUNE 2002
RABIES - WHAT CAN BE DONE? view more (2002-05-15)
Letrozole following tamoxifen may benefit women with breast cancer
Switching to the drug letrozole following 5 years of treatment with tamoxifen reduces the risk of hormone-dependent breast cancer recurrence, but not overall survival, among postmenopausal women. view more (2005-09-07)
Omega-3 fatty acids may slow down early Alzheimer's in some cases
Omega-3 fatty acid supplements may slow cognitive decline in some patients with very mild Alzheimer's disease, according to new findings from Karolinska Institutet (KI) in Sweden. view more (2006-10-11)
Common PTSD drug is no more effective than placebo
Guanfacine, a medication commonly prescribed to alleviate symptoms of post-traumatic stress disorder, is no more effective than a placebo, according to a study led by researchers at the San Francisco VA Medical Center. view more (2006-12-04)
Use of hydrocortisone reduces incidence of atrial fibrillation after cardiac surgery
Patients who receive corticosteroids after cardiac surgery have a significantly lower risk of atrial fibrillation in the days following the surgery. view more (2007-04-11)
Taking The Sting Out Of Ant Stings (pp979, 1001)
Australian authors of a study in this week's issue of THE LANCET highlight how immunisation to desensitise people to the venom of the jack jumper ant shows great promise for preventing severe systemic reactions in people allergic to this venom. The jack jumper ant (Myrmecia pilosula) is responsible for about 90% of severe systemic reactions to... view more... (2003-03-20)
Anti-allergic mattress covers have no clinical benefit in patients with moderate to severe asthma
The use of anti-allergic mattress covers shows no clinical improvement in patients with moderate to severe asthma, who already use regular treatment. However, they do reduce the exposition of house dust mite during the night, shows research in Thorax. Thirty non-smoking patients with asthma and house dust mite allergy were included in the study.... view more... (2002-08-27)
Black cohosh does not relieve menopausal hot flashes, Group Health researchers find
The popular herbal supplement black cohosh does not relieve hot flashes among women going through menopause, according to a study by researchers from Group Health Cooperative, a Seattle-based health care system. view more (2006-12-19)
Vitamin supplementation could slow arteriosclerosis in heart-transplant patients (p 1108)
A US randomised trial in this week’s issue of THE LANCET suggests that vitamin C and E supplementation could be of clinical benefit in delaying the onset of arteriosclerosis in the first year after heart transplantation. Around 70% of patients develop arteriosclerosis within three years after heart transplantation, which is thought to be... view more... (2002-03-27)
Drug breakthrough for psoriasis sufferers
An international team led by a dermatologist at The University of Manchester has found that treatment with the emerging drug infliximab, marketed as Remicade, can quickly and significantly improve psoriasis symptoms. view more (2005-10-14)
Further evidence showing treatment benefits of beta interferon for multiple sclerosis (pp 1463, 1489)
Results of a European study in this week's issue of THE LANCET provide further evidence that patients with early symptoms of multiple sclerosis given a weekly injection with interferon beta are less likely to progress to full clinical disease after two years follow-up. The study showed that the drug reduced patients' loss of brain tissue compared... view more... (2004-10-20)
NEW STUDY SUGGESTS THYROID HRT "NO BETTER THAN PLACEBO" WHERE PATIENTS HAVE NORMAL THYROID LEVELS
Recent press reports have highlighted the suggestion that patients should be given thyroid hormones if they show the symptoms of hypothyroidism, even if they are biochemically normal. Now an important controlled study, presented at the British Endocrine Societies meeting in Birmingham, suggests that taking thyroxine gives no significant benefit to... view more... (2000-03-06)
|
|
| Page
3 of
26 |
519 Results |
|
|
|
Sort By:
Page Views | Date |
|
